Cone Beam CT for Breast Cancer Screening

This trial aims to improve breast cancer screening techniques by testing a new imaging method called Cone Beam CT (CBBCT). Participants will either come from a routine screening group or have been flagged for possible breast issues requiring further diagnostic testing. The trial will compare CBBCT imaging with regular mammograms (digital mammography) to determine if it provides better data before any necessary biopsies. Women scheduled for routine mammograms or those with detected breast abnormalities might be suitable candidates. As an unphased trial, this study offers participants the opportunity to contribute to advancements in breast cancer screening technology.

The trial information does not specify whether you need to stop taking your current medications. It seems focused on imaging and does not mention medication restrictions.

Research has shown that Cone Beam CT (CBBCT) imaging is a promising tool for breast cancer screening. Studies have found that this method provides clear, three-dimensional images of the breast, allowing doctors to see more detail than traditional mammograms.

The FDA has approved the CBBCT device for breast imaging, confirming its safety for diagnosing breast issues. While standard precautions apply, as with most imaging devices, no major safety concerns have been reported.

Researchers are excited about Cone Beam CT (CBBCT) for breast cancer screening because it offers a promising new imaging method. Unlike traditional digital mammography, CBBCT provides 3D images, which can improve the detection of tumors, especially in dense breast tissue. This technique could potentially reduce the number of false positives and unnecessary biopsies. By delivering a more detailed view with less discomfort, CBBCT aims to enhance early detection and improve the overall screening experience for patients.

This trial will evaluate Cone Beam CT (CBBCT) for breast cancer screening. Research has shown that CBBCT surpasses digital mammography in diagnosing breast cancer. Studies indicate that CBBCT covers more breast tissue, enabling it to detect cancer more effectively. Although CBBCT is more accurate than standard digital mammography, it is slightly less effective than MRI. CBBCT proves particularly helpful in early breast cancer detection, which is crucial for successful treatment. While CBBCT remains under investigation, these findings suggest it could become a valuable tool for breast cancer screening and diagnosis.²³⁴⁶⁷